Lifelong Enzyme Therapy: A Call for Policy Change
Maharashtra BJP MP Anil Sukheorao Bonde emphasized the need for lifelong enzyme replacement therapy for children with rare diseases. Under current policy, financial support is limited, risking treatment discontinuation. Bonde suggests using CSR and core funding for uninterrupted therapy, which is crucial for children's growth and health.
- Country:
- India
Maharashtra BJP MP Anil Sukheorao Bonde has called on the government to ensure continuous life-saving Enzyme Replacement Therapy (ERT) for children with rare diseases. This plea was made during the Zero Hour in the Rajya Sabha on Friday.
Bonde highlighted the national policy on rare diseases emerged in 2021 to offer financial aid, providing up to Rs 50 lakh for treatments like ERT, crucial for managing conditions such as lysosomal storage disorders.
Bonde urged the government to consider extending this support, suggesting CSR and core funding be leveraged for uninterrupted therapy, emphasizing the dire consequences of treatment discontinuation.
Advertisement
ALSO READ
-
Two more Naxalites killed in ongoing operation in Maharashtra's Gadchiroli district; injured C-60 jawan succumbs: Police.
-
Unexpected Alliances: Shiv Sena Factions Unite for Local Maharashtra Polls
-
Maharashtra Fights Back: Aggressive Push to Eradicate Filariasis by 2030
-
Maharashtra's Forests at Crossroads: To Serve or Preserve?
-
Rival Shiv Sena Factions Unite for Local Polls Battle in Maharashtra